4-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-butyric acid

ID: ALA264070

PubChem CID: 9954406

Max Phase: Preclinical

Molecular Formula: C23H34N4O4

Molecular Weight: 430.55

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCCn1c(=O)c2nc([C@]34CC[C@](CCCC(=O)O)(CC3)CC4)[nH]c2n(CCC)c1=O

Standard InChI:  InChI=1S/C23H34N4O4/c1-3-14-26-18-17(19(30)27(15-4-2)21(26)31)24-20(25-18)23-11-8-22(9-12-23,10-13-23)7-5-6-16(28)29/h3-15H2,1-2H3,(H,24,25)(H,28,29)/t22-,23-

Standard InChI Key:  BGGPFCJYYBWGTM-YHBQERECSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  1  0  0  0  0  0999 V2000
   10.5214  -10.2934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5214  -11.1184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2340  -11.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9466  -11.1184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9466  -10.2934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2340   -9.8789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2336  -12.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5654  -12.8365    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9017  -12.8365    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6441  -13.6214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8179  -13.6222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4101  -14.3348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8196  -15.0510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6499  -15.0500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0623  -14.3329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4090  -15.7658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8873  -14.3308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5851  -14.3346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1707  -13.6196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3457  -13.6194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0604  -15.7649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8854  -15.7647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2998  -15.0497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2340   -9.0539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6117  -10.5546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8697  -10.7453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9490   -8.6393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6640   -9.0539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3790   -8.6393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0931   -9.0536    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3823   -7.8141    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 13 14  1  0
 14 15  1  0
  1  2  1  0
 13 16  2  0
  1  6  1  0
 15 17  2  0
  8 11  1  0
 12 18  1  0
 10  9  1  0
 18 19  1  0
  9  7  2  0
 19 20  1  0
  3  7  1  1
 14 21  1  0
 10 11  2  0
 21 22  1  0
  2  3  1  0
 22 23  1  0
  3  4  1  0
  6 24  1  1
  4  5  1  0
  6 25  1  0
  5  6  1  0
 25 26  1  0
  3 26  1  0
  7  8  1  0
 24 27  1  0
 27 28  1  0
 10 15  1  0
 28 29  1  0
 11 12  1  0
 12 13  1  0
 29 30  1  0
 29 31  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA264070

   4-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-butyric acid

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 430.55

Molecular Weight (Monoisotopic): 430.2580

AlogP: 3.55

#Rotatable Bonds: 9

Polar Surface Area: 109.98

Molecular Species: ACID

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 4.47

CX Basic pKa: 2.46

CX LogP: 3.88

CX LogD: 1.00

Aromatic Rings: 2

Heavy Atoms: 31

QED Weighted: 0.63

Np Likeness Score: -0.05

References

1. Kiesman WF, Zhao J, Conlon PR, Dowling JE, Petter RC, Lutterodt F, Jin X, Smits G, Fure M, Jayaraj A, Kim J, Sullivan G, Linden J..  (2006)  Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.,  49  (24): [PMID:17125264] [10.1021/jm0605381]

Source

Source(1):

• Scientific Literature